Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.verified

600521.SS

Price:

$17.33

Market Cap:

$25.82B

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-03-04

Stock Exchange

SHH

Ticker

600521.SS

The Enterprise Value as of December 2025 (TTM) for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) is 32.68B

According to Zhejiang Huahai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.68B. This represents a change of 1.60% compared to the average of 32.17B of the last 4 quarters.

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) Historical Enterprise Value (quarterly & annually)

How has 600521.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhejiang Huahai Pharmaceutical Co., Ltd. over the last ten years is 29.50B. The current 32.68B Enterprise Value has changed 10.98% with respect to the historical average. Over the past ten years (40 quarters), 600521.SS's Enterprise Value was at its highest in in the December 2020 quarter at 51.09B. The Enterprise Value was at its lowest in in the December 2018 quarter at 16.26B.

Quarterly (TTM)
Annual

Average

29.50B

Median

28.32B

Minimum

15.14B

Maximum

50.96B

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhejiang Huahai Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 106.93%

Maximum Annual Enterprise Value = 50.96B

Minimum Annual Increase = -53.24%

Minimum Annual Enterprise Value = 15.14B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202430.95B20.53%
202325.68B-30.75%
202237.09B5.24%
202135.24B-30.85%
202050.96B106.93%
201924.63B62.67%
201815.14B-53.24%
201732.38B42.06%
201622.79B12.87%
201520.19B78.38%

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) Average Enterprise Value

How has 600521.SS Enterprise Value performed in the past?

The current Enterprise Value of Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

31.24B

5-year avg

35.98B

10-year avg

29.50B

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) Enterprise Value vs. Peers

How is 600521.SS’s Enterprise Value compared to its peers?

Zhejiang Huahai Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Kangmei Pharmaceutical Co., Ltd. (25.98B), greater than Chengdu Kanghong Pharmaceutical Group Co., Ltd (24.11B), greater than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (25.42B), greater than Jiangsu Nhwa Pharmaceutical Co., Ltd. (23.64B), greater than Dong-E-E-Jiao Co.,Ltd. (26.09B), greater than Jilin Aodong Pharmaceutical Group Co., Ltd. (23.74B), greater than Betta Pharmaceuticals Co., Ltd. (21.71B), greater than Livzon Pharmaceutical Group Inc. (25.70B), greater than Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (29.08B), less than Humanwell Healthcare (Group) Co.,Ltd. (35.12B),

Build a custom stock screener for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Huahai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Huahai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Zhejiang Huahai Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)?

What is the 3-year average Enterprise Value for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)?

What is the 5-year average Enterprise Value for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)?

How does the current Enterprise Value for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) compare to its historical average?